Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Zonisamide recalled?

Not under an active recall. Zonisamide was recalled 13 times in the past — all now closed. Most recent: May 13, 2022.

Most common reason: cGMP deviation (9 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Zonisamide. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Zonisamide recalls on record

none so far in 2026; 13 on record, newest first
Class II · Moderate risk

Zonisamide Capsules USP

CGMP Deviations: Gaps in the quality system in the Quality Control microbiology laboratory.

Terminated Microbial contamination Direct Rx NDC 61919-775-90 D-0888-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-130-01 D-0793-2022
Class II · Moderate risk

Zonisamide Capsules

cGMP deviations

Completed cGMP deviation Glenmark Pharmaceuticals Inc., USA NDC 68462-129-01 D-0792-2022
Class II · Moderate risk

Zonisamide capsules

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation American Health Packaging NDC 68084-008-11 D-1230-2015
Class II · Moderate risk

Zonisamide Capsules

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1274-2015
Class II · Moderate risk

Zonisamide Capsules

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1273-2015
Class II · Moderate risk

Zonisamide Capsules

CGMP Deviations: Firm did not adequately investigate customer complaints.

Terminated cGMP deviation Wockhardt Usa Inc. D-1254-2015
Class II · Moderate risk

Zonisamide active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-960-2015
Class II · Moderate risk

ZONISAMIDE Capsule

Labeling: Label Mixup; ZONISAMIDE Capsule, 100 mg may be potentially mislabeled as PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: W003737, EXP: 5/31/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-693-2014